Fairvalue-Calculator Fairvalue-Calculator
EN DE

COFCO Biotechnology Co (000930) Fair Value & Analysis

Basic Materials · CN · Market cap 9.1B CNY

Price¥4.72
Fair Value¥2.15
Upside-54.4%
Quality92/100
Evidence: High Range ¥1.11 – ¥3.19

Analysis

COFCO Biotechnology Co (000930) currently trades at ¥4.72, while our model-based Fair Value estimate is ¥2.15 — implying the stock looks roughly 54.4% overvalued today. We read business quality at 92/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

COFCO Biotechnology Co., Ltd., together with its subsidiaries, engages in the processing and production of biochemical products in China. The company offers edible corn, special, waxy corn, and modified waxy corn starch; feed products, such as corn gluten meal, sprayed corn husk, corn germ meal, DDGS, fertilizer raw materials and glutamic acid residue; sweeteners comprising special syrup for frozen dough, compound fructose powder, maltodextrin, and fructose and glucose syrups; edible alcohol and fuel ethanol; and monosodium glutamate, anhydrous citric acid, potassium citrate, polylactic acid, phytosterols, and natural vitamin E. The company was formerly known as COFCO Biochemical (Anhui) Co., Ltd. and changed its name to COFCO Biotechnology Co., Ltd. in September 2019. The company was founded in 1998 and is based in Chaoyang, China.

Open the full interactive analysis →

Similar stocks

Linde plc (LIN) -57% L'Air Liquide S.A (AIQUY) -59% Air Products and Chemicals, Inc (A1PD34) -70% Intercontinental Exchange, Inc (I1CE34) -15% Wanhua Chemical Group (600309) -31% Asian Paints Limited (ASIANPAINT) -76%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.